JP Morgan Archives -

In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Jennifer Goldsack, CEO

The year ahead in digital health and life sciences: the pharmaphorum podcast

https://pharmaphorum.com/digital/the-year-ahead-in-digital-health-and-life-sciences/

Man using mobile smart phone with global network connection, Technology, innovative and communication concept.

Digital/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis

Digital health innovation in 2022: Anticipating healthcare trends ahead of the J.P. Morgan week

mike.smith@pharmaphorum.com Debiopharm, Debiopharm Innovation Fund, Innovation, JP Morgan, patient centricity 0 Comment

We spoke with Tanja Dowe, ahead of the annual J.P. Morgan Health Care Conference 2022, about radical innovation

Digital health innovation in 2022: Anticipating healthcare trends ahead of the J.P. Morgan week

https://pharmaphorum.com/digital/anticipating-innovative-digital-solutions-healthcare/

Market Access/ Views & Analysis/ Views and analysis

Haven: The strategy that didn’t fix healthcare

mike.hammerton@pharmaphorum.com Amazon, Berkshire Hathaway, Haven, JP Morgan, US 0 Comment

John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway,

Haven: The strategy that didn’t fix healthcare

https://pharmaphorum.com/views-analysis-market-access/haven-strategy-healthcare/

R&D/ Views & Analysis/ Views and analysis

Gene editing: beyond the hype

George Underwood CAR, CAR-Tregs, cell and gene therapy, cell therapy, CRISPR, gene editing, gene therapy, JP Morgan, Sangamo 0 Comment

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles

Gene editing: beyond the hype

https://pharmaphorum.com/r-d/views-analysis-r-d/genome-editing-sangamo-beyond-the-hype/

Digital/ Video/ Views & Analysis/ Views and analysis

Sanofi’s Bozidar Jovicevic on how the company is approaching digital therapeutics

Paul Tunnah digital therapeutics, JP Morgan, Sanofi 0 Comment

Paul Tunnah caught up with Sanofi’s vice president, global head of digital therapeutics at JP Morgan to talk

Sanofi’s Bozidar Jovicevic on how the company is approaching digital therapeutics

https://pharmaphorum.com/video/sanofis-bozidar-jovicevic-on-how-the-company-is-approaching-digital-therapeutics/

Digital/ Video/ Views & Analysis/ Views and analysis

UCB’s James Musick on embracing digital therapeutics

Paul Tunnah digital therapeutics, JP Morgan, UCB 0 Comment

Digital has rapidly taken over the pharma industry, but many still don’t fully understand how to harness it.

UCB’s James Musick on embracing digital therapeutics

https://pharmaphorum.com/views-analysis-digital/ucbs-james-musick-on-embracing-digital-therapeutics/

R&D/ Video/ Views & Analysis/ Views and analysis

Millendo’s Julia Owens on leadership in rare diseases

Paul Tunnah JP Morgan, Millendo Therapeutics, Prader-Willi syndrome, Rare diseases 0 Comment

Rare disease specialists Millendo Therapeutics are hoping their drug livoletide will become the first treatment for Prader-Willi syndrome.

Millendo’s Julia Owens on leadership in rare diseases

https://pharmaphorum.com/r-d/views-analysis-r-d/millendo-julia-owens-leadership-rare-diseases/

Oncology/ Video/ Views & Analysis/ Views and analysis

Helsinn’s Riccardo Braglia on the patient perspective in cancer care

mike.hammerton@pharmaphorum.com cancer care, Helsinn, JP Morgan 0 Comment

Swiss cancer care company Helsinn has become unique in the industry by remaining a family business over three

Helsinn’s Riccardo Braglia on the patient perspective in cancer care

https://pharmaphorum.com/views-analysis-oncology/helsinns-riccardo-braglia-patient-perspective-cancer-care/

Digital/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis

Pharma highlights from 2019 and a look ahead to 2020

Paul Tunnah 2019, digital health, frontiers health, JP Morgan, patient centricity 0 Comment

Paul Tunnah looks at the trends that defined this year in pharma and what they might mean for

Pharma highlights from 2019 and a look ahead to 2020

https://pharmaphorum.com/views-analysis-patients/pharma-highlights-2019-look-ahead-2020/

Trending

JP Morgan

Login